Association of lower levels of PUFAs in CRC tumor could be attributed to the pro-tumor genesis of cyclooxygenase 2 (COX-2), an enzyme converting PUFAs to prostaglandins during inflammatory and tumorigenic reactions44. The gene discussed is PTGS2; the disease is neoplasm.